Pharmaceutical

CHMP recommends full marketing approval for Gilead Scie...

Hepcludex has also received breakthrough therapy and orphan drug designations fr...

Siegfried buys 95% stake in biotechnology firm DiNAMIQS

The deal includes an option for Siegfried to purchase the remaining 5% five year...

WHO declares end of Covid-19 public health emergency

The WHO ended the public health emergency for Covid-19 as the pharma industry co...

FDA raises alarm about weight-gain supplement apetamin

The US FDA has warned that the illegally imported supplement apetamin has been l...

STAT+: A new list ranks large pharmaceutical companies ...

Idea Pharma ranks the largest pharmaceutical companies based on two measures: wh...

12,000 diseases lack treatments. One doctor thinks gene...

Using a unique AI tool, built from a half-dozen other algorithms, Every Cure is ...

STAT+: Option Care takes over Amedisys in ‘perplexing’ ...

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 bill...

Vinod Khosla’s bold AI prediction, digital therapeutics...

In the latest edition of STAT's Health Tech newsletter: Vinod Khosla's bold AI p...

CDC to cut back on Covid data it collects as public hea...

The ending of the public health emergency for Covid-19 will force the CDC to cut...

What explains rare heart condition among young men afte...

The study’s findings suggest that waiting more time between vaccine doses — to h...

STAT+: 4 ways the health care system should shift its t...

“People are thinking of ChatGPT as like a box. The progress in the field has not...

CDC Director Rochelle Walensky to step down

The director of the Centers for Disease Control and Prevention, Rochelle Walensk...

STAT+: Doudna talks cost, access issues looming over fi...

“How do we make sure that a technology like CRISPR — you know, no offense intend...

WHO declares end to Covid global health emergency

WHO announced the end of the Covid global health emergency three years after it ...

STAT+: Pharmalittle: Pfizer and Valneva delay applicati...

Moderna anticipates its updated Covid-19 vaccine will have a list price in a ran...

‘Patients are not hot potatoes’: How the fight over dia...

Patients with kidney failure continue to worry about losing access to dialysis, ...